Navigation Links
DrugRisk Update: New Pradaxa Study Questions FDA Safety Conclusion
Date:3/27/2013

Denver, CO (PRWEB) March 27, 2013

The prescription drug safety advocates at DrugRisk.com are announcing new information on the site for patients taking the blood thinner Pradaxa for atrial fibrillation. A new study presented this month has again raised questions over whether the drug has dangerous internal bleeding risks.

At DrugRisk, our goal is to improve the safety of prescription drug consumers by providing the latest alerts, recalls, studies and legal news. Patients with clear information can discuss side effect options with their doctor and decide if they need legal advice.

Information on the site shows health experts still disagree about the danger of Pradaxa internal bleeding. The FDA recently issued an advisory stating Pradaxa had the same risks as warfarin*. However, the Institute for Safe Medication Practices has ranked blood thinners like Pradaxa among the most dangerous drugs, and warned that patients suffering bleeding on Pradaxa are almost 5 times as likely to die than those with bleeding while taking warfarin**.

Now, DrugRisk has added a study from the University of Illinois at Chicago presented to the American College of Cardiology last week which warned that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Already, more than 260 patients have filed a Pradaxa lawsuit over allegations of internal bleeding, which have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

For more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.nejm.org/doi/full/10.1056/NEJMp1302834

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/side-effects-lawsuits/prweb10558658.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... MD (PRWEB) , ... August 20, 2017 , ... State ... one of 40 national causes up for a $25,000 grant. If the initiative wins, ... girl bullying – will expand into the Tri-County area of St. Mary’s, Calvert and ...
(Date:8/19/2017)... (PRWEB) , ... August 18, 2017 , ... ... partnership aimed at creating a transparent, verifiable database to help the cannabis industry ... ledger technology, Paragon hopes to deliver a faster technology with lower fees. Paragon ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has ... These illustrations show the diversity of the breastfeeding mothers, using bright colors ... of sizes. These illustrations are also available on tote bags, notepads, smartphone cases, ...
(Date:8/19/2017)... ... , ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a ... “Congratulations! It's A Boy! God’s Gift: A Story of Love” is the creation of ... , Published by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... highly specialized asset-light logistics provider of complex transport solutions for mission-critical and ... purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... , Aug. 2, 2017 CaryRx, a next-generation full-service ... delivery service for patients in the Washington D.C. ... retail pharmacy by providing delivery of medications through the convenience ... future delivery or delivered within one hour to any location ... excited to bring this invaluable service to Washington ...
Breaking Medicine Technology: